Lucid Diagnostics EBIT Margin 2021-2025 | LUCD

Lucid Diagnostics ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Lucid Diagnostics EBIT Margin 2021-2025 | LUCD

Lucid Diagnostics ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$174B
Intuitive Surgical (ISRG)$168.5B
IDEXX Laboratories (IDXX)$52.6B
Edwards Lifesciences (EW)$46B
Alcon (ALC)$42.3B
DexCom (DXCM)$30.9B
IQVIA Holdings (IQV)$30.6B
Mettler-Toledo (MTD)$25.9B
STERIS (STE)$23.9B
Waters (WAT)$16.7B
SONOVA HOLDING (SONVY)$16.6B
Hologic (HOLX)$15.1B
Penumbra (PEN)$9.4B
Sysmex ADR (SSMXY)$8.7B
Globus Medical (GMED)$7.9B
Masimo (MASI)$7.9B
Teleflex (TFX)$5.2B
Glaukos (GKOS)$4.9B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.7B
Alphatec Holdings (ATEC)$2.2B
Veracyte (VCYT)$2.2B
PROCEPT BioRobotics (PRCT)$2.1B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Artivion (AORT)$1.7B
Paragon 28 (FNA)$1.1B
Integra LifeSciences Holdings (IART)$1B
OPKO Health (OPK)$992M